Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FASTENAL COFAST · Entity 3012 | Chief Financial Officer/EVP | March 14, 2025 | March 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FASTENAL CO
Report date March 14, 2025 · Filed March 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,173 |
Reported balance
After 2025-03-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-14 · Exercise / conversion · Acquired 23,076 · Balance 33,173 |
| Common StockSEC Table I · non-derivative | Direct | 10,097 |
Reported balance
After 2025-03-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-03-14 · Sale · Disposed 23,076 · Balance 10,097 |
| Common StockSEC Table I · non-derivative | Direct | 25,886 |
Reported balance
After 2025-03-14 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2025-03-14 · Exercise / conversion · Acquired 15,789 · Balance 25,886 |
| Common StockSEC Table I · non-derivative | Direct | 10,097 |
Reported balance
After 2025-03-14 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2025-03-14 · Sale · Disposed 15,798 · Balance 10,097 |
| Common StockSEC Table I · non-derivative | Direct | 20,097 |
Reported balance
After 2025-03-14 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2025-03-14 · Exercise / conversion · Acquired 10,000 · Balance 20,097 |
| Common StockSEC Table I · non-derivative | Direct | 10,097 |
Reported balance
After 2025-03-14 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2025-03-14 · Sale · Disposed 10,000 · Balance 10,097 |
| Common StockSEC Table I · non-derivative | Direct | 16,338 |
Reported balance
After 2025-03-14 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2025-03-14 · Exercise / conversion · Acquired 6,241 · Balance 16,338 |
| Common StockSEC Table I · non-derivative | Direct | 10,097 |
Reported balance
After 2025-03-14 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2025-03-14 · Sale · Disposed 6,241 · Balance 10,097 |
| Common StockSEC Table I · non-derivative | Direct | 19,951 |
Reported balance
After 2025-03-14 transaction · row 9
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 9 · 2025-03-14 · Exercise / conversion · Acquired 9,854 · Balance 19,951 |
| Common StockSEC Table I · non-derivative | Direct | 10,097 |
Reported balance
After 2025-03-14 transaction · row 10
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 10 · 2025-03-14 · Sale · Disposed 9,854 · Balance 10,097 |
| Common StockSEC Table I · non-derivative | Direct | 13,792 |
Reported balance
After 2025-03-14 transaction · row 11
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 11 · 2025-03-14 · Exercise / conversion · Acquired 3,695 · Balance 13,792 |
| Common StockSEC Table I · non-derivative | Direct | 10,097 |
Reported balance
After 2025-03-14 transaction · row 12
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 12 · 2025-03-14 · Sale · Disposed 3,695 · Balance 10,097 F1: Shares held in a living Trust maintained by the reporting person and his spouse. |
| Employee Stock Option (Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $26.00 · Expires 2028-12-31 | Direct | 0 |
Reported balance
After 2025-03-14 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-03-14 · Exercise / conversion · Disposed 23,076 · Balance 0 F2: The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock split on 5/22/2019. F3: The option will vest and become exercisable over a period of five years, with 25% of the option vesting and becoming exercisable two years following the grant date and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. |
| Employee Stock Option (Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $64.00 · Expires 2033-12-31 | Direct | 14,781 |
Reported balance
After 2025-03-14 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-03-14 · Exercise / conversion · Disposed 3,695 · Balance 14,781 F5: The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.00 · Expires 2029-12-31 | Direct | 0 |
Reported balance
After 2025-03-14 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-03-14 · Exercise / conversion · Disposed 15,789 · Balance 0 F4: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately each year thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.00 · Expires 2030-12-31 | Direct | 2,500 |
Reported balance
After 2025-03-14 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-03-14 · Exercise / conversion · Disposed 10,000 · Balance 2,500 F4: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately each year thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.00 · Expires 2031-12-31 | Direct | 4,162 |
Reported balance
After 2025-03-14 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-03-14 · Exercise / conversion · Disposed 6,241 · Balance 4,162 F4: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately each year thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.00 · Expires 2032-12-31 | Direct | 14,781 |
Reported balance
After 2025-03-14 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-03-14 · Exercise / conversion · Disposed 9,854 · Balance 14,781 F5: The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held in a living Trust maintained by the reporting person and his spouse.
F2: The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock split on 5/22/2019.
F3: The option will vest and become exercisable over a period of five years, with 25% of the option vesting and becoming exercisable two years following the grant date and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.
F4: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately each year thereafter.
F5: The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2017 Filed May 26, 2017 20:46 UTC | FASTENAL CO FAST · Entity 3012 | PurchaseCommon Stock | 1,000 | $43.76 | $43,760.00 |
DisclosureSEC source: 0001179110-17-008133 · edgar.xml · nonDerivative · entry 1 Lewis Holden · CIK 0001681628 · Chief Financial Officer/EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:43 UTC | FASTENAL CO FAST · Entity 3012 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,532 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000489 · edgar.xml · derivative · entry 1 Lewis Holden · CIK 0001681628 · Chief Financial Officer/EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,532 Underlying: Common Stock · 25,532 shares Expires 2026-12-31 F1 · derivative.exercise_date: These options will fully vest and become exercisable over a period of five years, with 50% vesting and becoming exercisable halfway through the relevant vesting period, and the remainder vesting and becoming exercisable incrementally (20%, 20% and 10%) each year thereafter. Read SEC document |
| January 03, 2017 Filed Jan 21, 2017 00:14 UTC Amendment | FASTENAL CO FAST · Entity 3012 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,532 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001135 · edgar.xml · derivative · entry 1 Lewis Holden · CIK 0001681628 · Chief Financial Officer/EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,532 Underlying: Common Stock · 25,532 shares Expires 2026-12-31 F1 · derivative.exercise_date: The Date Exercisable was inaccurately reported in the Form 4 filed on January 5, 2017 and these options will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder becoming exercisable proportionately (20%, 20% and 20%) each year thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.